Association of dopamine receptor D1 (DRD1) polymorphisms with risperidone treatment response in Chinese schizophrenia patients

Ran Huo(University of Iowa), Shengying Qin(Shanghai Jiao Tong University), Donghong Cui(Shanghai Jiao Tong University), Jiajun Shi(North West Agriculture and Forestry University), Wenqiang Li(Henan Provincial Institute of Occupational Health), Yichen Liu(University of Notre Dame), Qinghe Xing(Shanghai Children's Medical Center), Jie Jiang(Shanghai Institutes for Biological Sciences), Lin He(Shanghai Institutes for Biological Sciences), Yucai Yan(Shanghai Institutes for Biological Sciences), Yuyu Xiong(Henan University of Technology), Zhiyun Wei(Obstetrics and Gynecology Hospital of Fudan University)
Neuroscience Letters
August 29, 2014
10.1016/j.neulet.2014.08.041
Cited by 16

Related Papers

Cytochrome P450 Enzymes and Drug Metabolism in Humans
|International Journal of Molecular Sciences|2021|939
Comparative genetic architectures of schizophrenia in East Asian and European populations
|Nature Genetics|2019|709
Coding and noncoding landscape of extracellular RNA released by human glioma stem cells
|Nature Communications|2017|549
Does green finance investment impact on sustainable development: Role of technological innovation and renewable energy
|Renewable Energy|2023|160
MiR-140 is co-expressed with<i>Wwp2-C</i>transcript and activated by Sox9 to target<i>Sp1</i>in maintaining the chondrocyte proliferation
|FEBS Letters|2011|142